Effect of Calcination Temperature on Cu-Modified Ni Catalysts Supported on Mesocellular Silica for Methane Decomposition

Catalytic methane decomposition has been considered suitable for the green and sustainable production of high-purity H₂ to help reduce greenhouse gas emissions. This research developed a copper-modified nickel-supported mesocellular silica NiCu/MS(x) catalyst synthesized at different calcination temperatures to improve the activity and stability in the CH₄ decomposition reaction at 600 °C. Ni and Cu metals were loaded on a mesocellular silica (MS) support using a co-impregnation method and calcined at different temperatures (500, 600, 700, and 800 °C). The NiCu/MS(600) catalyst not only had the highest H₂ yield (32.78%), which was 1.47-3.87 times higher than those of the other NiCu/MS(x) catalysts, but also showed better stability during the reaction. Calcination at 600 °C helps improve the active nickel dispersion, the reducibility of the NiCu catalyst, and the interaction of the NiCu-MS support, leading to the formation of fishbone and platelet carbon nanofibers via a tip-growth mechanism, resulting in the NiCu metals remaining active during the reaction.

Utilizing Quantitative Proteomics to Identify Species-Specific Protein Therapeutic Targets for the Treatment of Leishmaniasis

Leishmaniasis is a tropical disease caused by Leishmania parasites, which are transmitted through the bites of infected sandflies. We focused on the emergence of leishmaniasis in Thailand caused by a species (Leishmania orientalis). Treatment by chemotherapy is not effective against L. orientalis. Hence, we intended to solve this issue using a proteomics approach to investigate protein profiles and in silico analysis for the identification of antigenic proteins from L. orientalis, Leishmania martiniquensis, and Leishmania donovani. Using principal component analysis (PCA), protein profile comparisons indicated that different species of Leishmania are different at the protein level. Proteomics analysis identified 6099 proteins. Among these proteins, 1065 proteins were used for further analysis. There were 16 proteins that were promising candidates for therapeutic aspects as they were abundantly expressed and common to all species. In silico analysis of protein's antigenicity revealed that eight proteins had the potential for the development of antigenic molecules. Protein profile information and these antigenic proteins may play key roles in the pathogeny of leishmaniasis and can be used as novel therapeutic targets against leishmaniasis in the future.